Erste Asset Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$154K Hold
13,000
﹤0.01% 559
2026
Q1
$101K Hold
13,000
﹤0.01% 575
2025
Q4
$186K Hold
13,000
﹤0.01% 551
2025
Q3
$128K Hold
13,000
﹤0.01% 573
2025
Q2
$109K Hold
13,000
﹤0.01% 824
2025
Q1
$102K Hold
13,000
﹤0.01% 494
2024
Q4
$96.3K Hold
13,000
﹤0.01% 504
2024
Q3
$140K Hold
13,000
﹤0.01% 489
2024
Q2
$151K Hold
13,000
﹤0.01% 484
2024
Q1
$288K Hold
13,000
﹤0.01% 464
2023
Q4
$241K Hold
13,000
﹤0.01% 477
2023
Q3
$230K Hold
13,000
﹤0.01% 470
2023
Q2
$258K Hold
13,000
﹤0.01% 473
2023
Q1
$235K Hold
13,000
﹤0.01% 480
2022
Q4
$297K Hold
13,000
0.01% 459
2022
Q3
$324K Hold
13,000
0.01% 469
2022
Q2
$315K Hold
13,000
0.01% 473
2022
Q1
$430K Hold
13,000
0.01% 451
2021
Q4
$426K Hold
13,000
0.01% 438
2021
Q3
$547K Hold
13,000
0.01% 393
2021
Q2
$500K Hold
13,000
0.01% 411
2021
Q1
$437K Hold
13,000
0.01% 394
2020
Q4
$604K Hold
13,000
0.02% 373
2020
Q3
$363K Hold
13,000
0.01% 370
2020
Q2
$480K Hold
13,000
0.02% 345
2020
Q1
$439K Hold
13,000
0.03% 316
2019
Q4
$527K Hold
13,000
0.02% 325
2019
Q3
$434K Hold
13,000
0.02% 328
2019
Q2
$646K Hold
13,000
0.03% 292
2019
Q1
$722K Buy
+13,000
New +$644K 0.04% 276

Other funds holding RGNX

Erste Asset Management's RGNX Position: Q2 2026 in Review

Erste Asset Management held its Regenxbio (RGNX) position steady in Q2 2026 at 13,000 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Erste Asset Management first reported a position in RGNX in Q1 2019 and has held it in 30 quarters since. The position peaked at $722K in Q1 2019. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Erste Asset Management held 13,000 shares of Regenxbio worth $154K as of Q2 2026.
  • Erste Asset Management left its Regenxbio share count unchanged in Q2 2026.
  • Regenxbio made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #559 holding.
  • Erste Asset Management first reported a position in Regenxbio in Q1 2019 and has held it in 30 quarters since.
  • Erste Asset Management's Regenxbio position peaked at $722K in Q1 2019.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.